Back to BALYASNY ASSET MANAGEMENT L.P. BALYASNY ASSET MANAGEMENT L.P.

APGEAPGE
8 quarters

Position history for BALYASNY ASSET MANAGEMENT L.P.BALYASNY ASSET MANAGEMENT L.P.'s holdings in APOGEE THERAPEUTICS INC

BALYASNY ASSET MANAGEMENT L.P. holds 1.7M shares of APGE (APOGEE THERAPEUTICS INC), worth $221M as of 2026-Q2. The position was increased (+279.6% shares). APGE represents 0.3% of BALYASNY ASSET MANAGEMENT L.P.'s portfolio.

Current Value

$221M

Current Shares

1.7M

Total Value Change

+$220.8M

Total Shares Change

+1.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.7M
+279.6%
$221M0.3%$132.73
59
2026-Q1
New
438,654
-
$36.9M0.0%$68.50
40
2025-Q4
Exited
0
-100.0%
$00.0%$75.76
0
2025-Q3
Decreased
72,348
-54.4%
$2.9M0.0%$39.83
0
2025-Q2
Increased
158,635
+40.7%
$6.9M0.0%$43.38
36
2025-Q1
New
112,730
-
$4.2M0.0%$39.72
37
2024-Q2
Exited
0
-100.0%
$00.0%$39.35
0
2024-Q1
New
3,561
-
$236,6280.0%$66.45
32

Other major holders of APGE: FMR LLC, BlackRock, Inc., HBK INVESTMENTS L P, WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used